Chimeric receptors broaden the therapeutic landscape for autoimmune disease

Emerging research suggests that chimeric antigen receptor T cell therapy could be an effective treatment for a range of difficult-to-treat autoimmune diseases, and sophisticated approaches are in tests, yet initial reports also highlight several questions that remain to be answered.

Automated summary

Emerging research suggests that chimeric antigen receptor T cell therapy could effectively treat difficult-to-treat autoimmune diseases, but there are still unanswered questions according to initial reports.